Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,141 to 2,160 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Two m6A Readers YTHDF1 and IGF2BP2 as Immune Biomarkers in Head and Neck Squamous Cell Carcinoma. | Front Genet | 2022 | 35646049 | PubTator, text mining | PubMed |
| DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer. | RNA Biol | 2022 | 35638109 | PubTator, text mining | PubMed |
| METTL3 promotes cell cycle progression via m6A/YTHDF1-dependent regulation of CDC25B translation. | Int J Biol Sci | 2022 | 35637959 | PubTator, text mining | PubMed |
| Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases. | Int J Mol Sci | 2022 | 35628623 | PubTator, text mining | PubMed |
| The Advances in Epigenetics for Cancer Radiotherapy. | Int J Mol Sci | 2022 | 35628460 | PubTator, text mining | PubMed |
| Effect of Humantenine on mRNA m6A Modification and Expression in Human Colon Cancer Cell Line HCT116. | Genes (Basel) | 2022 | 35627166 | PubTator, text mining | PubMed |
| The Roles and Regulation of m6A Modification in Glioblastoma Stem Cells and Tumorigenesis. | Biomedicines | 2022 | 35625706 | PubTator, text mining | PubMed |
| Prospective Application of Ferroptosis in Hypoxic Cells for Tumor Radiotherapy. | Antioxidants (Basel) | 2022 | 35624785 | PubTator, text mining | PubMed |
| The impact of RNA modifications on the biology of DNA virus infection. | Eur J Cell Biol | 2022 | 35623231 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified RNA acts as a molecular glue that drives liquid-liquid phase separation in plants. | Plant Signal Behav | 2022 | 35621186 | PubTator, text mining | PubMed |
| N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia. | Front Genet | 2022 | 35615374 | PubTator, text mining | PubMed |
| ROBO1 p.E280* Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal. | Front Oncol | 2022 | 35615148 | PubTator, text mining | PubMed |
| Research Progress of RNA Methylation Modification in Colorectal Cancer. | Front Pharmacol | 2022 | 35614935 | PubTator, text mining | PubMed |
| Prognostic score model based on six m6A-related autophagy genes for predicting survival in esophageal squamous cell carcinoma. | J Clin Lab Anal | 2022 | 35611939 | PubTator, text mining | PubMed |
| A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms. | Neuroendocrinology | 2022 | 35609514 | PubTator, text mining | PubMed |
| A Network Pharmacology Study to Explore the Underlying Mechanism of Safflower (Carthamus tinctorius L.) in the Treatment of Coronary Heart Disease. | Evid Based Complement Alternat Med | 2022 | 35607519 | PubTator, text mining | PubMed |
| N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma. | Cancer Cell Int | 2022 | 35606813 | PubTator, text mining | PubMed |
| Enzymatic Characterization of In Vitro Activity of RNA Methyltransferase PCIF1 on DNA. | Biochemistry | 2022 | 35605980 | PubTator, text mining | PubMed |
N6 -methyladenosine-RNA methylation promotes expression of solute carrier family 7 member 11, an uptake transporter of cystine for lipid reactive oxygen species scavenger glutathione synthesis, leading to hepatoblastoma ferroptosis resistance. | Clin Transl Med | 2022 | 35604883 | PubTator, text mining | PubMed |
| Comprehensive Analysis of N6-Methyladenosine-Related Long Noncoding RNA Prognosis of Acute Myeloid Leukemia and Immune Cell Infiltration. | Front Genet | 2022 | 35601490 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=108